vs

Side-by-side financial comparison of ENANTA PHARMACEUTICALS INC (ENTA) and FRANKLIN STREET PROPERTIES CORP (FSP). Click either name above to swap in a different company.

FRANKLIN STREET PROPERTIES CORP is the larger business by last-quarter revenue ($26.0M vs $18.6M, roughly 1.4× ENANTA PHARMACEUTICALS INC). FRANKLIN STREET PROPERTIES CORP runs the higher net margin — -28.1% vs -64.1%, a 36.0% gap on every dollar of revenue. On growth, ENANTA PHARMACEUTICALS INC posted the faster year-over-year revenue change (9.8% vs -8.2%). ENANTA PHARMACEUTICALS INC produced more free cash flow last quarter ($-11.8M vs $-12.7M). Over the past eight quarters, ENANTA PHARMACEUTICALS INC's revenue compounded faster (4.5% CAGR vs -8.7%).

Enanta Pharmaceuticals Inc is a clinical-stage biotechnology company that develops innovative antiviral therapies for infectious diseases including hepatitis B virus, respiratory syncytial virus (RSV), and SARS-CoV-2. It operates primarily in the U.S. and global markets, partnering with pharmaceutical firms to advance its small molecule drug candidate pipeline for patients with unmet medical needs.

Franklin Street Properties Corp is a Massachusetts-based real estate investment trust (REIT) in the United States. It primarily invests in, owns, and operates high-quality office properties across major U.S. metropolitan markets, serving corporate tenants across various industry segments, and delivers stable long-term returns via rental income and strategic asset management.

ENTA vs FSP — Head-to-Head

Bigger by revenue
FSP
FSP
1.4× larger
FSP
$26.0M
$18.6M
ENTA
Growing faster (revenue YoY)
ENTA
ENTA
+18.0% gap
ENTA
9.8%
-8.2%
FSP
Higher net margin
FSP
FSP
36.0% more per $
FSP
-28.1%
-64.1%
ENTA
More free cash flow
ENTA
ENTA
$820.0K more FCF
ENTA
$-11.8M
$-12.7M
FSP
Faster 2-yr revenue CAGR
ENTA
ENTA
Annualised
ENTA
4.5%
-8.7%
FSP

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ENTA
ENTA
FSP
FSP
Revenue
$18.6M
$26.0M
Net Profit
$-11.9M
$-7.3M
Gross Margin
59.4%
Operating Margin
-60.5%
-27.9%
Net Margin
-64.1%
-28.1%
Revenue YoY
9.8%
-8.2%
Net Profit YoY
46.4%
14.1%
EPS (diluted)
$-0.42
$-0.06

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ENTA
ENTA
FSP
FSP
Q4 25
$18.6M
$26.0M
Q3 25
$15.1M
$27.3M
Q2 25
$18.3M
$26.7M
Q1 25
$14.9M
$27.1M
Q4 24
$17.0M
$28.4M
Q3 24
$14.6M
$29.7M
Q2 24
$18.0M
$30.8M
Q1 24
$17.1M
$31.2M
Net Profit
ENTA
ENTA
FSP
FSP
Q4 25
$-11.9M
$-7.3M
Q3 25
$-18.7M
$-8.3M
Q2 25
$-18.3M
$-7.9M
Q1 25
$-22.6M
$-21.4M
Q4 24
$-22.3M
$-8.5M
Q3 24
$-28.8M
$-15.6M
Q2 24
$-22.7M
$-21.0M
Q1 24
$-31.2M
$-7.6M
Gross Margin
ENTA
ENTA
FSP
FSP
Q4 25
59.4%
Q3 25
60.9%
Q2 25
59.9%
Q1 25
62.8%
Q4 24
59.7%
Q3 24
61.0%
Q2 24
64.2%
Q1 24
64.7%
Operating Margin
ENTA
ENTA
FSP
FSP
Q4 25
-60.5%
-27.9%
Q3 25
-121.6%
-30.5%
Q2 25
-103.2%
-29.2%
Q1 25
-164.3%
-78.9%
Q4 24
-138.8%
-29.9%
Q3 24
-204.4%
-52.4%
Q2 24
-134.6%
-68.0%
Q1 24
-192.1%
-24.0%
Net Margin
ENTA
ENTA
FSP
FSP
Q4 25
-64.1%
-28.1%
Q3 25
-123.6%
-30.5%
Q2 25
-99.7%
-29.5%
Q1 25
-151.7%
-79.1%
Q4 24
-131.4%
-30.0%
Q3 24
-197.3%
-52.6%
Q2 24
-126.1%
-68.2%
Q1 24
-182.7%
-24.2%
EPS (diluted)
ENTA
ENTA
FSP
FSP
Q4 25
$-0.42
$-0.06
Q3 25
$-0.88
$-0.08
Q2 25
$-0.85
$-0.08
Q1 25
$-1.06
$-0.21
Q4 24
$-1.05
$-0.09
Q3 24
$-1.36
$-0.15
Q2 24
$-1.07
$-0.20
Q1 24
$-1.47
$-0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ENTA
ENTA
FSP
FSP
Cash + ST InvestmentsLiquidity on hand
$37.4M
$30.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$126.6M
$607.0M
Total Assets
$329.5M
$892.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ENTA
ENTA
FSP
FSP
Q4 25
$37.4M
$30.6M
Q3 25
$32.3M
$31.4M
Q2 25
$44.8M
$29.4M
Q1 25
$60.2M
$30.2M
Q4 24
$84.3M
$41.1M
Q3 24
$37.2M
$40.9M
Q2 24
$35.8M
$30.2M
Q1 24
$63.5M
$34.2M
Stockholders' Equity
ENTA
ENTA
FSP
FSP
Q4 25
$126.6M
$607.0M
Q3 25
$64.7M
$615.3M
Q2 25
$79.3M
$624.7M
Q1 25
$93.5M
$633.4M
Q4 24
$111.8M
$655.9M
Q3 24
$128.8M
$665.4M
Q2 24
$148.9M
$682.1M
Q1 24
$166.1M
$703.9M
Total Assets
ENTA
ENTA
FSP
FSP
Q4 25
$329.5M
$892.9M
Q3 25
$280.7M
$901.0M
Q2 25
$301.0M
$903.2M
Q1 25
$323.0M
$916.4M
Q4 24
$348.6M
$946.9M
Q3 24
$376.7M
$981.5M
Q2 24
$398.8M
$1.0B
Q1 24
$413.6M
$1.0B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ENTA
ENTA
FSP
FSP
Operating Cash FlowLast quarter
$-11.7M
$3.8M
Free Cash FlowOCF − Capex
$-11.8M
$-12.7M
FCF MarginFCF / Revenue
-63.6%
-48.6%
Capex IntensityCapex / Revenue
0.8%
63.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-18.5M
$-25.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ENTA
ENTA
FSP
FSP
Q4 25
$-11.7M
$3.8M
Q3 25
$-6.5M
$8.3M
Q2 25
$17.5M
$-2.9M
Q1 25
$-13.5M
$-5.5M
Q4 24
$-16.8M
$9.0M
Q3 24
$-10.4M
$14.5M
Q2 24
$-14.8M
$-648.0K
Q1 24
$-28.6M
$-7.1M
Free Cash Flow
ENTA
ENTA
FSP
FSP
Q4 25
$-11.8M
$-12.7M
Q3 25
$-7.9M
$3.0M
Q2 25
$17.4M
$-5.7M
Q1 25
$-16.0M
$-9.9M
Q4 24
$-25.5M
$-16.2M
Q3 24
$-19.4M
$8.6M
Q2 24
$-21.3M
$-5.1M
Q1 24
$-30.3M
$-15.8M
FCF Margin
ENTA
ENTA
FSP
FSP
Q4 25
-63.6%
-48.6%
Q3 25
-52.5%
11.0%
Q2 25
94.7%
-21.5%
Q1 25
-107.4%
-36.7%
Q4 24
-150.6%
-57.2%
Q3 24
-132.5%
29.1%
Q2 24
-118.6%
-16.7%
Q1 24
-177.5%
-50.8%
Capex Intensity
ENTA
ENTA
FSP
FSP
Q4 25
0.8%
63.0%
Q3 25
9.6%
19.4%
Q2 25
0.8%
10.7%
Q1 25
17.0%
16.4%
Q4 24
51.6%
88.9%
Q3 24
61.3%
19.6%
Q2 24
36.4%
14.6%
Q1 24
9.8%
28.1%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons